Genome Editing Market Size, Share & Trends Analysis Report By Technology (CRISPR, ZFN, TALEN), By Delivery Method (Ex-vivo, In-vivo), By Application, By Mode, By End-use, By Region, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1. Genome Editing Market: Methodology and Scope
                   1.1. Information Procurement
                   1.2. Information or Data Analysis
                   1.3. Market Scope & Segment Definition
                   1.4. Market Model
                       1.4.1. Market Study, By Company Market Share
                       1.4.2. Regional Analysis
Chapter 2. Genome Editing Market: Executive Summary
                   2.1. Market Snapshot
                   2.2. Segment Snapshot
                   2.3. Competitive Landscape Snapshot
Chapter 3. Genome Editing Market: Variables, Trends, & Scope
                   3.1. Market Segmentation and Scope
                   3.2. Market Lineage Outlook
                       3.2.1. Parent Market Outlook
                       3.2.2. Related/Ancillary Market Outlook
                   3.3. Market Trends and Outlook
                   3.4. Market Dynamics
                       3.4.1. Success in pre-clinical models drives demands for genome editing therapeutics
                       3.4.2. Rising competition amongst market participants for business development
                       3.4.3. Easy editing solutions for the development of therapeutics for a broad range of diseases
                       3.4.4. Increasing demand for synthetic genes and genetically modified organisms
                       3.4.5. Technological advancements in gene editing technologies
                       3.4.6. Rising adoption in agricultural biotechnology
                   3.5. Market Restraint Analysis
                       3.5.1. Challenges concerning clinical translation
                       3.5.2. Regulatory, scientific, and ethical challenges regarding the use of genetically modified products
                       3.5.3. Off-target effects of CRISPR technology
                   3.6. Business Environment Analysis
                   3.7. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
                   3.8. Porter’s Five Forces Analysis
                   3.9. COVID-19 Impact Analysis
Chapter 4. Technology Business Analysis
                   4.1. Genome Editing Market: Technology Movement Analysis
                   4.2. Genome EditingTechnology Comparison
                   4.3. (CRISPR)/Cas9
                       4.3.1. Global (CRISPR)/Cas9 market, 2018 - 2030 (USD Million)
                   4.4. TALENs/MegaTALs
                       4.4.1. Global TALENs/MegaTALs market, 2018 - 2030 (USD Million)
                   4.5. ZFN
                       4.5.1. Global ZFN market, 2018 - 2030 (USD Million)
                   4.6. Meganucleases
                       4.6.1. Global Meganucleases market, 2018 - 2030 (USD Million)
                   4.7. Other Technologies
                       4.7.1. Global other technologies market, 2018 - 2030 (USD Million)
Chapter 5. Delivery Method Business Analysis
                   5.1. Genome Editing Market: Delivery Method Movement Analysis
                       5.1.1. Comparison of Delivery Methods
                           5.1.1.1. Viral delivery
                               5.1.1.1.1. AAV (Adeno Associated Virus)
                               5.1.1.1.2. IDLV (Integrase Deficient Lentivirus).
                           5.1.1.2. Non-viral delivery
                               5.1.1.2.1. Lipid Mediated
                               5.1.1.2.2. Electroporation
                   5.2. Ex-vivo
                       5.2.1. Global ex-vivo delivery market, 2018 - 2030 (USD Million)
                   5.3. In-vivo
                       5.3.1. Global in-vivo delivery market, 2018 - 2030 (USD Million)
Chapter 6. Application Business Analysis
                   6.1. Genome Editing Market: Application Movement Analysis
                   6.2. Genetic Engineering
                       6.2.1. Genetic Engineering Market, 2018 - 2030 (USD Million)
                           6.2.1.1. Cell line engineering
                               6.2.1.1.1. Cell line engineering Market, 2018 - 2030 (USD Million)
                           6.2.1.2. Animal genetic engineering
                               6.2.1.2.1. Animal genetic engineering Market, 2018 - 2030 (USD Million)
                           6.2.1.3. Plant genetic engineering
                               6.2.1.3.1. Plant genetic engineering Market, 2018 - 2030 (USD Million)
                           6.2.1.4. Others
                               6.2.1.4.1. Global others market, 2018 - 2030 (USD Million)
                   6.3. Clinical Applications
                       6.3.1. Market for clinical applications, 2018 - 2030 (USD Million)
                           6.3.1.1. Diagnostics
                               6.3.1.1.1. Market for diagnostics applications, 2018 - 2030 (USD Million)
                           6.3.1.2. Therapy Development
                               6.3.1.2.1. Market for therapy development applications, 2018 - 2030 (USD Million)
Chapter 7. End-User Business Analysis
                   7.1. Genome Editing Market: End-User Movement Analysis
                   7.2. Biotechnology & Pharmaceutical Companies
                       7.2.1. Biotechnology & Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
                   7.3. Academic & Government Research Institutes
                       7.3.1. Academic & Government Research Institutes Market, 2018 - 2030 (USD Million)
                   7.4. Contract Research Organizations (CROs)
                       7.4.1. Contract Research Organizations (CROs) Market, 2018 - 2030 (USD Million)
Chapter 8. Genome Editing Market: Mode Business Analysis
                   8.1. Genome Editing Market: Mode Movement Analysis
                   8.2. In-house
                       8.2.1. In-house Market, 2018 - 2030 (USD Million)
                   8.3. Contract
                       8.3.1. Contract Market, 2018 - 2030 (USD Million)
Chapter 9. Regional Business Analysis
                   9.1. Genome Editing Market Share By Region, 2022 & 2030
                   9.2. North America
                       9.2.1. SWOT Analysis
                       9.2.2. North America genome editing market, 2018 - 2030 (USD Million)
                       9.2.3. U.S.
                           9.2.3.1. Key Country Dynamics
                           9.2.3.2. Competitive Scenario
                           9.2.3.3. Regulatory Framework
                           9.2.3.4. Target Disease Prevalence
                           9.2.3.5. U.S. genome editing market, 2018 - 2030 (USD Million)
                       9.2.4. Canada
                           9.2.4.1. Key Country Dynamics
                           9.2.4.2. Competitive Scenario
                           9.2.4.3. Regulatory Framework
                           9.2.4.4. Target Disease Prevalence
                           9.2.4.5. Canada genome editing market, 2018 - 2030 (USD Million)
                   9.3. Europe
                       9.3.1. SWOT Analysis
                       9.3.2. Europe genome editing market, 2018 - 2030 (USD Million)
                       9.3.3. Germany
                           9.3.3.1. Key Country Dynamics
                           9.3.3.2. Competitive Scenario
                           9.3.3.3. Regulatory Framework
                           9.3.3.4. Target Disease Prevalence
                           9.3.3.5. Germany genome editing market, 2018 - 2030 (USD Million)
                       9.3.4. UK
                           9.3.4.1. Key Country Dynamics
                           9.3.4.2. Competitive Scenario
                           9.3.4.3. Regulatory Framework
                           9.3.4.4. Target Disease Prevalence
                           9.3.4.5. UK genome editing market, 2018 - 2030 (USD Million)
                       9.3.5. France
                           9.3.5.1. Key Country Dynamics
                           9.3.5.2. Competitive Scenario
                           9.3.5.3. Regulatory Framework
                           9.3.5.4. Target Disease Prevalence
                           9.3.5.5. France genome editing market, 2018 - 2030 (USD Million)
                       9.3.6. Italy
                           9.3.6.1. Key Country Dynamics
                           9.3.6.2. Competitive Scenario
                           9.3.6.3. Regulatory Framework
                           9.3.6.4. Target Disease Prevalence
                           9.3.6.5. Italy genome editing market, 2018 - 2030 (USD Million)
                       9.3.7. Spain
                           9.3.7.1. Key Country Dynamics
                           9.3.7.2. Competitive Scenario
                           9.3.7.3. Regulatory Framework
                           9.3.7.4. Target Disease Prevalence
                           9.3.7.5. Spain genome editing market, 2018 - 2030 (USD Million)
                       9.3.8. Denmark
                           9.3.8.1. Key Country Dynamics
                           9.3.8.2. Competitive Scenario
                           9.3.8.3. Regulatory Framework
                           9.3.8.4. Target Disease Prevalence
                           9.3.8.5. Denmark genome editing market, 2018 - 2030 (USD Million)
                       9.3.9. Sweden
                           9.3.9.1. Key Country Dynamics
                           9.3.9.2. Competitive Scenario
                           9.3.9.3. Regulatory Framework
                           9.3.9.4. Target Disease Prevalence
                           9.3.9.5. Sweden genome editing market, 2018 - 2030 (USD Million)
                       9.3.10. Norway
                           9.3.10.1. Key Country Dynamics
                           9.3.10.2. Competitive Scenario
                           9.3.10.3. Regulatory Framework
                           9.3.10.4. Target Disease Prevalence
                           9.3.10.5. Norway genome editing market, 2018 - 2030 (USD Million)
                   9.4. Asia Pacific
                       9.4.1. SWOT Analysis
                       9.4.2. Asia Pacific genome editing market, 2018 - 2030 (USD Million)
                       9.4.3. Japan
                           9.4.3.1. Key Country Dynamics
                           9.4.3.2. Competitive Scenario
                           9.4.3.3. Regulatory Framework
                           9.4.3.4. Target Disease Prevalence
                           9.4.3.5. Japan genome editing market, 2018 - 2030 (USD Million)
                       9.4.4. China
                           9.4.4.1. Key Country Dynamics
                           9.4.4.2. Competitive Scenario
                           9.4.4.3. Regulatory Framework
                           9.4.4.4. Target Disease Prevalence
                           9.4.4.5. China genome editing market, 2018 - 2030 (USD Million)
                       9.4.5. India
                           9.4.5.1. Key Country Dynamics
                           9.4.5.2. Competitive Scenario
                           9.4.5.3. Regulatory Framework
                           9.4.5.4. Target Disease Prevalence
                           9.4.5.5. India genome editing market, 2018 - 2030 (USD Million)
                       9.4.6. South Korea
                           9.4.6.1. Key Country Dynamics
                           9.4.6.2. Competitive Scenario
                           9.4.6.3. Regulatory Framework
                           9.4.6.4. Target Disease Prevalence
                           9.4.6.5. South Korea genome editing market, 2018 - 2030 (USD Million)
                       9.4.7. Australia
                           9.4.7.1. Key Country Dynamics
                           9.4.7.2. Competitive Scenario
                           9.4.7.3. Regulatory Framework
                           9.4.7.4. Target Disease Prevalence
                           9.4.7.5. Australia genome editing market, 2018 - 2030 (USD Million)
                       9.4.8. Thailand
                           9.4.8.1. Key Country Dynamics
                           9.4.8.2. Competitive Scenario
                           9.4.8.3. Regulatory Framework
                           9.4.8.4. Target Disease Prevalence
                           9.4.8.5. Thailand genome editing market, 2018 - 2030 (USD Million)
                   9.5. Latin America
                       9.5.1. SWOT Analysis
                       9.5.2. Latin America genome editing market, 2018 - 2030 (USD Million)
                       9.5.3. Brazil
                           9.5.3.1. Key Country Dynamics
                           9.5.3.2. Competitive Scenario
                           9.5.3.3. Regulatory Framework
                           9.5.3.4. Target Disease Prevalence
                           9.5.3.5. Brazil genome editing market, 2018 - 2030 (USD Million)
                       9.5.4. Mexico
                           9.5.4.1. Key Country Dynamics
                           9.5.4.2. Competitive Scenario
                           9.5.4.3. Regulatory Framework
                           9.5.4.4. Target Disease Prevalence
                           9.5.4.5. Mexico genome editing market, 2018 - 2030 (USD Million)
                       9.5.5. Argentina
                           9.5.5.1. Key Country Dynamics
                           9.5.5.2. Competitive Scenario
                           9.5.5.3. Regulatory Framework
                           9.5.5.4. Target Disease Prevalence
                           9.5.5.5. Argentina genome editing market, 2018 - 2030 (USD Million)
                   9.6. MEA
                       9.6.1. SWOT Analysis
                       9.6.2. MEA genome editing market, 2018 - 2030 (USD Million)
                       9.6.3. South Africa
                           9.6.3.1. Key Country Dynamics
                           9.6.3.2. Competitive Scenario
                           9.6.3.3. Regulatory Framework
                           9.6.3.4. Target Disease Prevalence
                           9.6.3.5. South Africa genome editing market, 2018 - 2030 (USD Million)
                       9.6.4. Saudi Arabia
                           9.6.4.1. Key Country Dynamics
                           9.6.4.2. Competitive Scenario
                           9.6.4.3. Regulatory Framework
                           9.6.4.4. Target Disease Prevalence
                           9.6.4.5. Saudi Arabia genome editing market, 2018 - 2030 (USD Million)
                       9.6.5. UAE
                           9.6.5.1. Key Country Dynamics
                           9.6.5.2. Competitive Scenario
                           9.6.5.3. Regulatory Framework
                           9.6.5.4. Target Disease Prevalence
                           9.6.5.5. UAE genome editing market, 2018 - 2030 (USD Million)
                       9.6.6. Kuwait
                           9.6.6.1. Key Country Dynamics
                           9.6.6.2. Competitive Scenario
                           9.6.6.3. Regulatory Framework
                           9.6.6.4. Target Disease Prevalence
                           9.6.6.5. Kuwait genome editing market, 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
                   10.1. Company Categorization
                   10.2. Strategy Mapping
                   10.3. Company Profiles/Listing
                       10.3.1. Merck KGaA
                           10.3.1.1. Overview
                               10.3.1.1.1. Sigma-Aldrich Co. LLC
                           10.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.3.1.3. Product Benchmarking
                           10.3.1.4. Strategic Initiatives
                       10.3.2. Cibus
                           10.3.2.1. Overview
                                10.3.2.1.1. Nucelis
                           10.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.3.2.3. Product Benchmarking
                           10.3.2.4. Strategic Initiatives
                       10.3.3. Recombinetics, Inc
                           10.3.3.1. Overview
                           10.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.3.3.3. Product Benchmarking
                           10.3.3.4. Strategic Initiatives
                       10.3.4. Sangamo
                           10.3.4.1. Overview
                           10.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.3.4.3. Product Benchmarking
                           10.3.4.4. Strategic Initiatives
                       10.3.5. Editas Medicine
                           10.3.5.1. Overview
                           10.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.3.5.3. Product Benchmarking
                           10.3.5.4. Strategic Initiatives
                       10.3.6. Precision Biosciences
                           10.3.6.1. Overview
                           10.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.3.6.3. Product Benchmarking
                           10.3.6.4. Strategic Initiatives
                       10.3.7. CRISPR THERAPEUTICS
                           10.3.7.1. Overview
                           10.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.3.7.3. Product Benchmarking
                           10.3.7.4. Strategic Initiatives
                       10.3.8. Intellia Therapeutics, Inc.
                           10.3.8.1. Overview
                           10.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.3.8.3. Product Benchmarking
                           10.3.8.4. Strategic Initiatives
                       10.3.9. Caribou Biosciences, Inc
                           10.3.9.1. Overview
                           10.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.3.9.3. Product Benchmarking
                           10.3.9.4. Strategic Initiatives
                       10.3.10. Cellectis
                           10.3.10.1. Overview
                           10.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.3.10.3. Product Benchmarking
                           10.3.10.4. Strategic Initiatives
                       10.3.11. AstraZeneca
                           10.3.11.1. Overview
                           10.3.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.3.11.3. Product Benchmarking
                           10.3.11.4. Strategic Initiatives
                       10.3.12. Takara Bio Inc.
                           10.3.12.1. Overview
                           10.3.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.3.12.3. Product Benchmarking
                           10.3.12.4. Strategic Initiatives
                       10.3.13. Horizon Discovery Group plc
                           10.3.13.1. Overview
                           10.3.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.3.13.3. Product Benchmarking
                           10.3.13.4. Strategic Initiatives
                       10.3.14. Integrated DNA Technologies, Inc.
                           10.3.14.1. Overview
                           10.3.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.3.14.3. Product Benchmarking
                           10.3.14.4. Strategic Initiatives
                       10.3.15. Transposagen Biopharmaceuticals, Inc.
                           10.3.15.1. Overview
                           10.3.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.3.15.3. Product Benchmarking
                           10.3.15.4. Strategic Initiatives
                       10.3.16. GenScript
                           10.3.16.1. Overview
                           10.3.16.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.3.16.3. Product Benchmarking
                           10.3.16.4. Strategic Initiatives
                       10.3.17. New England Biolabs
                           10.3.17.1. Overview
                           10.3.17.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.3.17.3. Product Benchmarking
                           10.3.17.4. Strategic Initiatives
                       10.3.18. OriGene Technologies, Inc.
                           10.3.18.1. Overview
                           10.3.18.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.3.18.3. Product Benchmarking
                           10.3.18.4. Strategic Initiatives
                       10.3.19. bluebird bio, Inc.
                           10.3.19.1. Overview
                           10.3.19.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.3.19.3. Product Benchmarking
                           10.3.19.4. Strategic Initiatives
                       10.3.20. Lonza
                           10.3.20.1. Overview
                           10.3.20.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.3.20.3. Product Benchmarking
                           10.3.20.4. Strategic Initiatives
                       10.3.21. Thermo Fisher Scientific, Inc.
                           10.3.21.1. Overview
                           10.3.21.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.3.21.3. Product Benchmarking
                           10.3.21.4. Strategic Initiatives

List of Tables

Table 1 List of Abbreviations
Table 2 Global genome editing market, by technology, 2018 - 2030 (USD Million)
Table 3 Global genome editing market, by delivery method, 2018 - 2030 (USD Million)
Table 4 Global genome editing market, by application, 2018 - 2030 (USD Million)
Table 5 Global genome editing market, by mode, 2018 - 2030 (USD Million)
Table 6 Global genome editing market, by end-use, 2018 - 2030 (USD Million)
Table 7 Global genome editing market, by region, 2018 - 2030 (USD Million)
Table 8 North America genome editing market, by country, 2018 - 2030 (USD Million)
Table 9 North America genome editing market, by technology, 2018 - 2030 (USD Million)
Table 10 North America genome editing market, by delivery method, 2018 - 2030 (USD Million)
Table 11 North America genome editing market, by application, 2018 - 2030 (USD Million)
Table 12 North America genome editing market, by end-use, 2018 - 2030 (USD Million)
Table 13 North America genome editing market, by mode, 2018 - 2030 (USD Million)
Table 14 U.S. genome editing market, by technology, 2018 - 2030 (USD Million)
Table 15 U.S. genome editing market, by delivery method, 2018 - 2030 (USD Million)
Table 16 U.S. genome editing market, by application, 2018 - 2030 (USD Million)
Table 17 U.S. genome editing market, by end-use, 2018 - 2030 (USD Million)
Table 18 U.S. genome editing market, by mode, 2018 - 2030 (USD Million)
Table 19 Canada genome editing market, by technology, 2018 - 2030 (USD Million)
Table 20 Canada genome editing market, by delivery method, 2018 - 2030 (USD Million)
Table 21 Canada genome editing market, by application, 2018 - 2030 (USD Million)
Table 22 Canada genome editing market, by end-use, 2018 - 2030 (USD Million)
Table 23 Canada genome editing market, by mode, 2018 - 2030 (USD Million)
Table 24 Europe genome editing market, by country, 2018 - 2030 (USD Million)
Table 25 Europe genome editing market, by technology, 2018 - 2030 (USD Million)
Table 26 Europe genome editing market, by delivery method, 2018 - 2030 (USD Million)
Table 27 Europe genome editing market, by application, 2018 - 2030 (USD Million)
Table 28 Europe genome editing market, by end-use, 2018 - 2030 (USD Million)
Table 29 Europe genome editing market, by mode, 2018 - 2030 (USD Million)
Table 30 Germany genome editing market, by technology, 2018 - 2030 (USD Million)
Table 31 Germany genome editing market, by delivery method, 2018 - 2030 (USD Million)
Table 32 Germany genome editing market, by application, 2018 - 2030 (USD Million)
Table 33 Germany genome editing market, by end-use, 2018 - 2030 (USD Million)
Table 34 Germany genome editing market, by mode, 2018 - 2030 (USD Million)
Table 35 UK genome editing market, by technology, 2018 - 2030 (USD Million)
Table 36 UK genome editing market, by delivery method, 2018 - 2030 (USD Million)
Table 37 UK genome editing market, by application, 2018 - 2030 (USD Million)
Table 38 UK genome editing market, by end-use, 2018 - 2030 (USD Million)
Table 39 UK genome editing market, by mode, 2018 - 2030 (USD Million)
Table 40 France genome editing market, by technology, 2018 - 2030 (USD Million)
Table 41 France genome editing market, by delivery method, 2018 - 2030 (USD Million)
Table 42 France genome editing market, by application, 2018 - 2030 (USD Million)
Table 43 France genome editing market, by end-use, 2018 - 2030 (USD Million)
Table 44 France genome editing market, by mode, 2018 - 2030 (USD Million)
Table 45 Italy genome editing market, by technology, 2018 - 2030 (USD Million)
Table 46 Italy genome editing market, by delivery method, 2018 - 2030 (USD Million)
Table 47 Italy genome editing market, by application, 2018 - 2030 (USD Million)
Table 48 Italy genome editing market, by end-use, 2018 - 2030 (USD Million)
Table 49 Italy genome editing market, by mode, 2018 - 2030 (USD Million)
Table 50 Spain genome editing market, by technology, 2018 - 2030 (USD Million)
Table 51 Spain genome editing market, by delivery method, 2018 - 2030 (USD Million)
Table 52 Spain genome editing market, by application, 2018 - 2030 (USD Million)
Table 53 Spain genome editing market, by end-use, 2018 - 2030 (USD Million)
Table 54 Spain genome editing market, by mode, 2018 - 2030 (USD Million)
Table 55 Denmark genome editing market, by technology, 2018 - 2030 (USD Million)
Table 56 Denmark genome editing market, by delivery method, 2018 - 2030 (USD Million)
Table 57 Denmark genome editing market, by application, 2018 - 2030 (USD Million)
Table 58 Denmark genome editing market, by end-use, 2018 - 2030 (USD Million)
Table 59 Denmark genome editing market, by mode, 2018 - 2030 (USD Million)
Table 60 Sweden genome editing market, by technology, 2018 - 2030 (USD Million)
Table 61 Sweden genome editing market, by delivery method, 2018 - 2030 (USD Million)
Table 62 Sweden genome editing market, by application, 2018 - 2030 (USD Million)
Table 63 Sweden genome editing market, by end-use, 2018 - 2030 (USD Million)
Table 64 Sweden genome editing market, by mode, 2018 - 2030 (USD Million)
Table 65 Norway genome editing market, by technology, 2018 - 2030 (USD Million)
Table 66 Norway genome editing market, by delivery method, 2018 - 2030 (USD Million)
Table 67 Norway genome editing market, by application, 2018 - 2030 (USD Million)
Table 68 Norway genome editing market, by end-use, 2018 - 2030 (USD Million)
Table 69 Norway genome editing market, by mode, 2018 - 2030 (USD Million)
Table 70 Asia Pacific genome editing market, by country, 2018 - 2030 (USD Million)
Table 71 Asia Pacific genome editing market, by technology, 2018 - 2030 (USD Million)
Table 72 Asia Pacific genome editing market, by delivery method, 2018 - 2030 (USD Million)
Table 73 Asia Pacific genome editing market, by application, 2018 - 2030 (USD Million)
Table 74 Asia Pacific genome editing market, by end-use, 2018 - 2030 (USD Million)
Table 75 Asia Pacific genome editing market, by mode, 2018 - 2030 (USD Million)
Table 76 China genome editing market, by technology, 2018 - 2030 (USD Million)
Table 77 China genome editing market, by delivery method, 2018 - 2030 (USD Million)
Table 78 China genome editing market, by application, 2018 - 2030 (USD Million)
Table 79 China genome editing market, by end-use, 2018 - 2030 (USD Million)
Table 80 China genome editing market, by mode, 2018 - 2030 (USD Million)
Table 81 Japan genome editing market, by technology, 2018 - 2030 (USD Million)
Table 82 Japan genome editing market, by delivery method, 2018 - 2030 (USD Million)
Table 83 Japan genome editing market, by application, 2018 - 2030 (USD Million)
Table 84 Japan genome editing market, by end-use, 2018 - 2030 (USD Million)
Table 85 Japan genome editing market, by mode, 2018 - 2030 (USD Million)
Table 86 India genome editing market, by technology, 2018 - 2030 (USD Million)
Table 87 India genome editing market, by delivery method, 2018 - 2030 (USD Million)
Table 88 India genome editing market, by application, 2018 - 2030 (USD Million)
Table 89 India genome editing market, by end-use, 2018 - 2030 (USD Million)
Table 90 India genome editing market, by mode, 2018 - 2030 (USD Million)
Table 91 South Korea genome editing market, by technology, 2018 - 2030 (USD Million)
Table 92 South Korea genome editing market, by delivery method, 2018 - 2030 (USD Million)
Table 93 South Korea genome editing market, by application, 2018 - 2030 (USD Million)
Table 94 South Korea genome editing market, by end-use, 2018 - 2030 (USD Million)
Table 95 South Korea genome editing market, by mode, 2018 - 2030 (USD Million)
Table 96 Australia genome editing market, by technology, 2018 - 2030 (USD Million)
Table 97 Australia genome editing market, by delivery method, 2018 - 2030 (USD Million)
Table 98 Australia genome editing market, by application, 2018 - 2030 (USD Million)
Table 99 Australia genome editing market, by end-use, 2018 - 2030 (USD Million)
Table 100 Australia genome editing market, by mode, 2018 - 2030 (USD Million)
Table 101 Thailand genome editing market, by technology, 2018 - 2030 (USD Million)
Table 102 Thailand genome editing market, by delivery method, 2018 - 2030 (USD Million)
Table 103 Thailand genome editing market, by application, 2018 - 2030 (USD Million)
Table 104 Thailand genome editing market, by end-use, 2018 - 2030 (USD Million)
Table 105 Thailand genome editing market, by mode, 2018 - 2030 (USD Million)
Table 106 Latin America genome editing market, by country, 2018 - 2030 (USD Million)
Table 107 Latin America genome editing market, by technology, 2018 - 2030 (USD Million)
Table 108 Latin America genome editing market, by delivery method, 2018 - 2030 (USD Million)
Table 109 Latin America genome editing market, by application, 2018 - 2030 (USD Million)
Table 110 Latin America genome editing market, by end-use, 2018 - 2030 (USD Million)
Table 111 Latin America genome editing market, by mode, 2018 - 2030 (USD Million)
Table 112 Brazil genome editing market, by technology, 2018 - 2030 (USD Million)
Table 113 Brazil genome editing market, by delivery method, 2018 - 2030 (USD Million)
Table 114 Brazil genome editing market, by application, 2018 - 2030 (USD Million)
Table 115 Brazil genome editing market, by end-use, 2018 - 2030 (USD Million)
Table 116 Brazil genome editing market, by mode, 2018 - 2030 (USD Million)
Table 117 Mexico genome editing market, by technology, 2018 - 2030 (USD Million)
Table 118 Mexico genome editing market, by delivery method, 2018 - 2030 (USD Million)
Table 119 Mexico genome editing market, by application, 2018 - 2030 (USD Million)
Table 120 Mexico genome editing market, by end-use, 2018 - 2030 (USD Million)
Table 121 Mexico genome editing market, by mode, 2018 - 2030 (USD Million)
Table 122 Argentina genome editing market, by technology, 2018 - 2030 (USD Million)
Table 123 Argentina genome editing market, by delivery method, 2018 - 2030 (USD Million)
Table 124 Argentina genome editing market, by application, 2018 - 2030 (USD Million)
Table 125 Argentina genome editing market, by end-use, 2018 - 2030 (USD Million)
Table 126 Argentina genome editing market, by mode, 2018 - 2030 (USD Million)
Table 127 Middle East & Africa genome editing market, by country, 2018 - 2030 (USD Million)
Table 128 Middle East & Africa genome editing market, by technology, 2018 - 2030 (USD Million)
Table 129 Middle East & Africa genome editing market, by delivery method, 2018 - 2030 (USD Million)
Table 130 Middle East & Africa genome editing market, by application, 2018 - 2030 (USD Million)
Table 131 Middle East & Africa genome editing market, by end-use, 2018 - 2030 (USD Million)
Table 132 Middle East & Africa genome editing market, by mode, 2018 - 2030 (USD Million)
Table 133 South Africa genome editing market, by technology, 2018 - 2030 (USD Million)
Table 134 South Africa genome editing market, by delivery method, 2018 - 2030 (USD Million)
Table 135 South Africa genome editing market, by application, 2018 - 2030 (USD Million)
Table 136 South Africa genome editing market, by end-use, 2018 - 2030 (USD Million)
Table 137 South Africa genome editing market, by mode, 2018 - 2030 (USD Million)
Table 138 Saudi Arabia genome editing market, by technology, 2018 - 2030 (USD Million)
Table 139 Saudi Arabia genome editing market, by delivery method, 2018 - 2030 (USD Million)
Table 140 Saudi Arabia genome editing market, by application, 2018 - 2030 (USD Million)
Table 141 Saudi Arabia genome editing market, by end-use, 2018 - 2030 (USD Million)
Table 142 Saudi Arabia genome editing market, by mode, 2018 - 2030 (USD Million)
Table 143 UAE genome editing market, by technology, 2018 - 2030 (USD Million)
Table 144 UAE genome editing market, by delivery method, 2018 - 2030 (USD Million)
Table 145 UAE genome editing market, by application, 2018 - 2030 (USD Million)
Table 146 UAE genome editing market, by end-use, 2018 - 2030 (USD Million)
Table 147 Kuwait genome editing market, by technology, 2018 - 2030 (USD Million)
Table 148 Kuwait genome editing market, by delivery method, 2018 - 2030 (USD Million)
Table 149 Kuwait genome editing market, by application, 2018 - 2030 (USD Million)
Table 150 Kuwait genome editing market, by end-use, 2018 - 2030 (USD Million)
Table 151 Kuwait genome editing market, by mode, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Genome editing market segmentation
Fig. 8 Market snapshot, 2022
Fig. 9 Market trends & outlook
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Market restraint relevance analysis (Current & future impact)
Fig. 12 Swot analysis, by factor (political & legal, economic and technological)
Fig. 13 Porter’s five forces analysis
Fig. 14 Genome editing market: Technology outlook key takeaways
Fig. 15 Genome editing market: Technology movement analysis
Fig. 16 Global (CRISPR)/Cas9market, 2018 - 2030 (USD Million)
Fig. 17 Global TALENs/MegaTALs market, 2018 - 2030 (USD Million)
Fig. 18 Global ZFN market, 2018 - 2030 (USD Million)
Fig. 19 Global meganucleases market, 2018 - 2030 (USD Million)
Fig. 20 Global other technologies market, 2018 - 2030 (USD Million)
Fig. 21 Genome editing market: Delivery method outlook key takeaways
Fig. 22 Genome editing market: Delivery method movement analysis
Fig. 23 Global ex-vivo delivery market, 2018 - 2030 (USD Million)
Fig. 24 Global in-vivo delivery market, 2018 - 2030 (USD Million)
Fig. 25 Genome editing market: Application outlook key takeaways
Fig. 26 Global genome editing market: Application movement analysis
Fig. 27 Global genetic engineering market, 2018 - 2030 (USD Million)
Fig. 28 Global cell line engineering/ gene therapy market, 2018 - 2030 (USD Million)
Fig. 29 Global animal genetic engineering market, 2018 - 2030 (USD Million)
Fig. 30 Global plant genetic engineering market, 2018 - 2030 (USD Million)
Fig. 31 Global other applications market, 2018 - 2030 (USD Million)
Fig. 32 Global clinical applications market, 2018 - 2030 (USD Million)
Fig. 33 Global diagnostic applications market, 2018 - 2030 (USD Million)
Fig. 34 Global therapy development applications market, 2018 - 2030 (USD Million)
Fig. 35 Genome editing market: End-use outlook key takeaways
Fig. 36 Global genome editing market: End-use movement analysis
Fig. 37 Global biotechnology & pharmaceutical companies market, 2018 - 2030 (USD Million)
Fig. 38 Global academic & government research institutes market, 2018 - 2030 (USD Million)
Fig. 39 Global CROs market, 2018 - 2030 (USD Million)
Fig. 40 Genome editing market: Mode outlook key takeaways
Fig. 41 Global genome editing market: Mode movement analysis
Fig. 42 Global in-house gene editing market, 2018 - 2030 (USD Million)
Fig. 43 Global contract gene editing market, 2018 - 2030 (USD Million)
Fig. 44 Regional marketplace: Key takeaway
Fig. 45 Genome editing regional outlook, 2020 & 2028
Fig. 46 Regional marketplace: key takeaways
Fig. 47 Regional outlook, 2022 & 2030
Fig. 48 Global genome editing market: region movement analysis
Fig. 49 North America genome editing market, 2018 - 2030 (USD Million)
Fig. 50 U.S. genome editing market, 2018 - 2030 (USD Million)
Fig. 51 Canada genome editing market, 2018 - 2030 (USD Million)
Fig. 52 Europe genome editing market, 2018 - 2030 (USD Million)
Fig. 53 Germany genome editing market, 2018 - 2030 (USD Million)
Fig. 54 UK genome editing market, 2018 - 2030 (USD Million)
Fig. 55 France genome editing market, 2018 - 2030 (USD Million)
Fig. 56 Italy genome editing market, 2018 - 2030 (USD Million)
Fig. 57 Spain genome editing market, 2018 - 2030 (USD Million)
Fig. 58 Denmark genome editing market, 2018 - 2030 (USD Million)
Fig. 59 Sweden genome editing market, 2018 - 2030 (USD Million)
Fig. 60 Norway genome editing market, 2018 - 2030 (USD Million)
Fig. 61 Asia Pacific genome editing market, 2018 - 2030 (USD Million)
Fig. 62 Japan genome editing market, 2018 - 2030 (USD Million)
Fig. 63 China genome editing market, 2018 - 2030 (USD Million)
Fig. 64 India genome editing market, 2018 - 2030 (USD Million)
Fig. 65 Australia genome editing market, 2018 - 2030 (USD Million)
Fig. 66 South Korea genome editing market, 2018 - 2030 (USD Million)
Fig. 67 Thailand genome editing market, 2018 - 2030 (USD Million)
Fig. 68 Latin America genome editing market, 2018 - 2030 (USD Million)
Fig. 69 Brazil genome editing market, 2018 - 2030 (USD Million)
Fig. 70 Mexico genome editing market, 2018 - 2030 (USD Million)
Fig. 71 Argentina genome editing market, 2018 - 2030 (USD Million)
Fig. 72 Middle East and Africa genome editing market, 2018 - 2030 (USD Million)
Fig. 73 South Africa genome editing market, 2018 - 2030 (USD Million)
Fig. 74 Saudi Arabia genome editing market, 2018 - 2030 (USD Million)
Fig. 75 UAE genome editing market, 2018 - 2030 (USD Million
Fig. 76 Kuwait genome editing market, 2018 - 2030 (USD Million)